Financial Ratios Danaher Corporation
Stocks
DHR
US2358511028
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 201.11 USD | -1.33% |
|
+1.03% | -12.15% |
| Jul. 20 | Zonebourse earnings calendar for company results: July 21, 2026 | |
| Jul. 20 | Zonebourse corporate earnings calendar: week of July 20 to 24, 2026 |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.41 | 6.52 | 3.98 | 3.98 | 4.18 | |||||
Return on Total Capital | 7.83 | 7.85 | 4.68 | 4.61 | 4.84 | |||||
Return On Equity % | 14.94 | 15.13 | 8.15 | 7.57 | 7.05 | |||||
Return on Common Equity | 15.77 | 15.73 | 8.24 | 7.57 | 7.05 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 61.3 | 60.21 | 59.14 | 59.61 | 59.23 | |||||
SG&A Margin | 27.66 | 26.89 | 30.33 | 31.38 | 30.84 | |||||
EBITDA Margin % | 35.09 | 34.84 | 31.59 | 31.44 | 31.85 | |||||
EBITA Margin % | 32.66 | 32.49 | 28.77 | 28.42 | 28.8 | |||||
EBIT Margin % | 27.73 | 27.78 | 22.52 | 21.59 | 21.89 | |||||
Income From Continuing Operations Margin % | 21.55 | 22.91 | 17.67 | 16.33 | 14.65 | |||||
Net Income Margin % | 21.84 | 22.91 | 19.94 | 16.33 | 14.71 | |||||
Net Avail. For Common Margin % | 20.99 | 22.57 | 17.58 | 16.33 | 14.65 | |||||
Normalized Net Income Margin | 16.85 | 17.02 | 14.12 | 13.07 | 13.08 | |||||
Levered Free Cash Flow Margin | 18.59 | 17.75 | 20.33 | 19.56 | 18.51 | |||||
Unlevered Free Cash Flow Margin | 19.1 | 18.17 | 21.08 | 20.29 | 19.19 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.37 | 0.38 | 0.28 | 0.29 | 0.31 | |||||
Fixed Assets Turnover | 6.52 | 6.43 | 4.69 | 4.09 | 3.83 | |||||
Receivables Turnover (Average Receivables) | 6.74 | 6.48 | 5.86 | 6.4 | 6.6 | |||||
Inventory Turnover (Average Inventory) | 4.51 | 4.26 | 3.64 | 3.92 | 4.16 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.43 | 1.89 | 1.68 | 1.4 | 1.87 | |||||
Quick Ratio | 0.89 | 1.43 | 1.28 | 0.95 | 1.4 | |||||
Operating Cash Flow to Current Liabilities | 1.03 | 1.02 | 0.87 | 0.98 | 0.94 | |||||
Days Sales Outstanding (Average Receivables) | 54.16 | 56.33 | 62.3 | 57.17 | 55.34 | |||||
Days Outstanding Inventory (Average Inventory) | 81.01 | 85.65 | 100.2 | 93.44 | 87.81 | |||||
Average Days Payable Outstanding | 70.99 | 69.01 | 68.93 | 68.65 | 64.52 | |||||
Cash Conversion Cycle (Average Days) | 64.18 | 72.97 | 93.57 | 81.95 | 78.63 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 51.51 | 41.4 | 36.52 | 34.6 | 37.49 | |||||
Total Debt / Total Capital | 34 | 29.28 | 26.75 | 25.71 | 27.27 | |||||
LT Debt/Equity | 51.04 | 39.83 | 33.02 | 33.24 | 37.1 | |||||
Long-Term Debt / Total Capital | 33.68 | 28.16 | 24.18 | 24.69 | 26.99 | |||||
Total Liabilities / Total Assets | 45.69 | 40.62 | 36.69 | 36.1 | 37.05 | |||||
EBIT / Interest Expense | 34.32 | 41.43 | 18.81 | 18.54 | 20.29 | |||||
EBITDA / Interest Expense | 44.71 | 53.44 | 27.35 | 28.08 | 30.72 | |||||
(EBITDA - Capex) / Interest Expense | 39.27 | 47.98 | 22.51 | 23.07 | 26.36 | |||||
Total Debt / EBITDA | 2.19 | 1.84 | 2.5 | 2.2 | 2.42 | |||||
Net Debt / EBITDA | 1.94 | 1.31 | 1.75 | 1.93 | 1.85 | |||||
Total Debt / (EBITDA - Capex) | 2.49 | 2.05 | 3.03 | 2.67 | 2.82 | |||||
Net Debt / (EBITDA - Capex) | 2.21 | 1.46 | 2.12 | 2.35 | 2.16 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 32.17 | 6.85 | -10.33 | -0.06 | 2.9 | |||||
Gross Profit, 1 Yr. Growth % | 38.43 | 4.95 | -12.72 | 0.72 | 2.26 | |||||
EBITDA, 1 Yr. Growth % | 56.32 | 6.08 | -22.29 | -0.54 | 3.66 | |||||
EBITA, 1 Yr. Growth % | 60.97 | 6.32 | -23.76 | -1.27 | 3.62 | |||||
EBIT, 1 Yr. Growth % | 68.86 | 7.03 | -29.01 | -4.22 | 3.48 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 74.08 | 13.58 | -33.3 | -7.63 | -7.67 | |||||
Net Income, 1 Yr. Growth % | 76.44 | 12.06 | -33.92 | -18.16 | -7.31 | |||||
Normalized Net Income, 1 Yr. Growth % | 71.22 | 7.95 | -27.22 | -7.5 | 2.12 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 73.94 | 13.72 | -33.28 | -6.37 | -4.92 | |||||
Accounts Receivable, 1 Yr. Growth % | 12.68 | 6.42 | -4.86 | -9.82 | 10.63 | |||||
Inventory, 1 Yr. Growth % | 20.72 | 12.4 | -6.18 | -10.18 | 6.82 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 14.91 | 2.61 | 22.03 | 8.37 | 11.05 | |||||
Total Assets, 1 Yr. Growth % | 9.22 | 1.4 | 0.16 | -8.22 | 7.64 | |||||
Tangible Book Value, 1 Yr. Growth % | 9.52 | -47.41 | 2.13 | 7.37 | -11.43 | |||||
Common Equity, 1 Yr. Growth % | 14.8 | 15.55 | 10.48 | -7.37 | 6.04 | |||||
Cash From Operations, 1 Yr. Growth % | 34.63 | 1.93 | -15.91 | -6.64 | -4.07 | |||||
Capital Expenditures, 1 Yr. Growth % | 63.59 | -10.97 | 23.7 | 0.65 | -16.95 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 19.59 | 2 | 1.2 | -3.83 | -3.17 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 18.39 | 1.65 | 2.2 | -3.79 | -3.22 | |||||
Dividend Per Share, 1 Yr. Growth % | 16.67 | 19.05 | 5 | 2.86 | 18.52 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 28.23 | 18.84 | -1.86 | -5.34 | 1.41 | |||||
Gross Profit, 2 Yr. CAGR % | 34.48 | 20.53 | -4.04 | -6.24 | 1.78 | |||||
EBITDA, 2 Yr. CAGR % | 52.06 | 28.99 | -9.15 | -12.09 | 2.38 | |||||
EBITA, 2 Yr. CAGR % | 56.92 | 31.06 | -9.93 | -13.24 | 2.07 | |||||
EBIT, 2 Yr. CAGR % | 57.78 | 34.74 | -12.83 | -17.54 | 0.73 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 61.55 | 40.61 | -11.97 | -21.5 | -7.65 | |||||
Net Income, 2 Yr. CAGR % | 46.24 | 40.61 | -13.94 | -26.46 | -12.9 | |||||
Normalized Net Income, 2 Yr. CAGR % | 54.84 | 36.27 | -11.31 | -17.95 | -1.65 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 61.42 | 40.65 | -11.88 | -20.96 | -5.65 | |||||
Accounts Receivable, 2 Yr. CAGR % | 19.04 | 10.39 | -8.08 | -8 | -0.11 | |||||
Inventory, 2 Yr. CAGR % | 30.37 | 16.49 | -3.18 | -8.2 | -2.04 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 25.53 | 8.59 | 7.71 | 15 | 9.7 | |||||
Total Assets, 2 Yr. CAGR % | 15.75 | 5.24 | 0.78 | -4.12 | -0.61 | |||||
Tangible Book Value, 2 Yr. CAGR % | 141.57 | -24.1 | -36.69 | 4.72 | -2.48 | |||||
Common Equity, 2 Yr. CAGR % | 20.89 | 15.17 | 12.98 | 1.16 | -0.89 | |||||
Cash From Operations, 2 Yr. CAGR % | 45.43 | 17.14 | -7.42 | -11.4 | -5.36 | |||||
Capital Expenditures, 2 Yr. CAGR % | 42.64 | 20.68 | 5.61 | 11.58 | -8.57 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 33.14 | 10.61 | 1.48 | -1.35 | -2.71 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 33.48 | 9.86 | 1.78 | -0.84 | -2.75 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.14 | 17.85 | 11.8 | 3.92 | 10.41 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 19.99 | 20.67 | 2.35 | -1.26 | -2.67 | |||||
Gross Profit, 3 Yr. CAGR % | 23.85 | 23.81 | 2.7 | -2.48 | -3.49 | |||||
EBITDA, 3 Yr. CAGR % | 34.29 | 34.86 | 4.62 | -6.37 | -6.95 | |||||
EBITA, 3 Yr. CAGR % | 37.42 | 37.82 | 4.9 | -7.13 | -7.76 | |||||
EBIT, 3 Yr. CAGR % | 38.27 | 38.63 | 3.77 | -10.05 | -10.81 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 38.17 | 43.65 | 5 | -10.55 | -17.14 | |||||
Net Income, 3 Yr. CAGR % | 34.38 | 33.82 | 9.32 | -15.37 | -20.56 | |||||
Normalized Net Income, 3 Yr. CAGR % | 38.92 | 37.3 | 5.36 | -10.06 | -11.49 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 35.83 | 43.63 | 4.97 | -10.08 | -15.94 | |||||
Accounts Receivable, 3 Yr. CAGR % | 14.17 | 15.29 | -1.1 | -9.08 | -2.17 | |||||
Inventory, 3 Yr. CAGR % | 19.26 | 24.08 | 4.21 | -5.57 | -3.44 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 29.02 | 17.37 | 10.06 | 7.93 | 13.67 | |||||
Total Assets, 3 Yr. CAGR % | 20.26 | 10.76 | 3.52 | -2.31 | -0.35 | |||||
Tangible Book Value, 3 Yr. CAGR % | 68.21 | 45.32 | -24 | -24.5 | -0.97 | |||||
Common Equity, 3 Yr. CAGR % | 14.09 | 19.08 | 13.59 | 5.74 | 2.76 | |||||
Cash From Operations, 3 Yr. CAGR % | 27.61 | 29.18 | 4.89 | -7.16 | -9.02 | |||||
Capital Expenditures, 3 Yr. CAGR % | 30.37 | 21.9 | 20.47 | 3.93 | 1.12 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 26.84 | 21.83 | 2.08 | -0.32 | -1.77 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 26.65 | 21.9 | 2.05 | -0.11 | -1.46 | |||||
Dividend Per Share, 3 Yr. CAGR % | 9.49 | 13.72 | 13.4 | 8.74 | 8.58 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 11.77 | 15.19 | 6.98 | 5.92 | 1.97 | |||||
Gross Profit, 5 Yr. CAGR % | 14.04 | 17.19 | 8.25 | 7.35 | 2.21 | |||||
EBITDA, 5 Yr. CAGR % | 20.72 | 24.13 | 12.08 | 10.92 | 3.5 | |||||
EBITA, 5 Yr. CAGR % | 22.5 | 26.3 | 13.14 | 11.68 | 3.51 | |||||
EBIT, 5 Yr. CAGR % | 22.98 | 27.42 | 11.73 | 9.45 | 2.24 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 24.13 | 27.11 | 11.9 | 9.9 | -0.25 | |||||
Net Income, 5 Yr. CAGR % | 20.3 | 23.67 | 12.44 | 5.33 | -0.18 | |||||
Normalized Net Income, 5 Yr. CAGR % | 23.91 | 28.25 | 12.75 | 8.56 | 2.19 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 22.51 | 25.7 | 10.75 | 10.16 | 0.59 | |||||
Accounts Receivable, 5 Yr. CAGR % | 7.77 | 7.3 | 5.02 | 1.59 | -0.98 | |||||
Inventory, 5 Yr. CAGR % | 10.11 | 11.06 | 9.72 | 7.43 | 1.66 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 15.46 | 15.09 | 20.03 | 14.65 | 9.92 | |||||
Total Assets, 5 Yr. CAGR % | 12.93 | 12.58 | 12.05 | 4.55 | 1.85 | |||||
Tangible Book Value, 5 Yr. CAGR % | 11.85 | 2.18 | 13.79 | 20.22 | -16.03 | |||||
Common Equity, 5 Yr. CAGR % | 12.74 | 12.93 | 13.65 | 11.56 | 7.56 | |||||
Cash From Operations, 5 Yr. CAGR % | 18.87 | 19.62 | 12.24 | 11.1 | 0.66 | |||||
Capital Expenditures, 5 Yr. CAGR % | 17.02 | 15.08 | 18.82 | 16.96 | 7.88 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 15.48 | 22.65 | 12.6 | 8.62 | -0.07 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 15.12 | 22.18 | 12.7 | 8.94 | -0.1 | |||||
Dividend Per Share, 5 Yr. CAGR % | 8.06 | 12.3 | 10.41 | 9.69 | 12.2 |
- Stock Market
- Stocks
- DHR Stock
- Financials Danaher Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















